Free Trial
OTCMKTS:LTUS

Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis

Lotus Pharmaceuticals logo
$0.0085 0.00 (-6.59%)
As of 08/29/2025 01:58 PM Eastern

About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)

Key Stats

Today's Range
$0.0085
$0.0085
50-Day Range
$0.0044
$0.0111
52-Week Range
$0.0006
$0.0111
Volume
645 shs
Average Volume
5,075 shs
Market Capitalization
$22.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LTUS Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
Lotus Pharmaceutical Co Ltd (1795) - Investing.com UK
Lotus Pharmaceuticals Inc Price / Book
See More Headlines

LTUS Stock Analysis - Frequently Asked Questions

Lotus Pharmaceuticals' stock was trading at $0.0060 at the beginning of the year. Since then, LTUS shares have increased by 41.7% and is now trading at $0.0085.

Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lotus Pharmaceuticals investors own include Vodafone Group (VOD), TILT (TLLTF), SolarWinds (SWI), Spectra Energy Partners (SEP), NextEra Energy (NEE), Energy Transfer (ET) and Ameriwest Lithium (AWLID).

Company Calendar

Today
8/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:LTUS
CIK
N/A
Employees
230
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,644,520,000
Free Float
N/A
Market Cap
$22.48 million
Optionable
Not Optionable
Beta
-2.54

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:LTUS) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners